Screening Newborns for Congenital Disorders

Wisconsin Medical Journal

Volumn 102, Issue 6, 2003, Pages 45-50

  Hoffman, Gary L ^a   Laessig, Ronald H ^a  

^a WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDEMIA; ARGININOSUCCINIC ACIDEMIA; BIOTINIDASE DEFICIENCY; BLOOD ANALYSIS; BLOOD SAMPLING; CITRULLINEMIA; CONGENITAL ADRENAL HYPERPLASIA; CYSTIC FIBROSIS; GALACTOSEMIA; HOMOCYSTINURIA; HUMAN; HYPOTHYROIDISM; LABORATORY TEST; LAW; MAPLE SYRUP URINE DISEASE; MENTAL DISEASE; NEWBORN; PHENYLKETONURIA; PRIMARY MEDICAL CARE; REVIEW; RISK ASSESSMENT; SICKLE CELL ANEMIA; TYROSINEMIA; UNITED STATES;

ABNORMALITIES; HUMANS; INFANT, NEWBORN; LABORATORIES; NEONATAL SCREENING; PUBLIC HEALTH ADMINISTRATION; STATE GOVERNMENT; WISCONSIN;

EID: 0344823818     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Health Resources Services Administration, the American Academy of Pediatrics, et al. Serving the family from birth to the medical home: a report from the Newborn Screening Task Force. Pediatrics. 2000;106(suppl):383-427.
2. Larson A, Therrell B. Newborn Screening: the role of the obstetrician. Clin Obstet Gynecol. 2003;45(3):687-710.
3. Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32:338-343.
4. Hoffman G, Laessig R, Makowski E, Hassemer D. Automated filter paper phenylalanine and galactose newborn screening system: design optimization with respect to cost, reliability, and legal responsibilities. Clin Chem. 1982;28(7):1553
5. Pass K, Levy H. Early Hospital Discharge: impact on Newborn Screening. National Maternal and Child Health Clearing House, Mclean, VA; 1995;1-289.
6. American Academy of Pediatrics, Committee on Genetics. Issues in newborn screening. Pediatrics. 1992;89(2):345-349.
7. Farrell P, Aronson R, Hoffman G, Laessig R. Newborn screening for cystic fibrosis in Wisconsin: first application of population-based molecular genetics testing. Wisc Med J. 1994;93(8):415-421.
8. Hoffman G, Litsheim T, Laessig, R. Implementation of tandem mass spectrometry in Wisconsin's newborn screening program. Morb Mortal Wkly Rep. 2001;50:26-27.